Hyperfine enrolls 100 patients in NEURO PMR study

Hyperfine (HYPR) announced the enrollment of 100 patients in its NEURO PMR study just 16 weeks after the study initiation, announced on April 15. The company said, “This milestone reflects strong clinician enthusiasm for accessible, point-of-care brain imaging and supports Hyperfine’s market expansion into outpatient neurology offices.”